Skip to main content
logo
Turnstone Biologics Corp. (TSBX)
Aug 11, 2025 - TSBX was delisted (reason: acquired by XOMA)
0.3550
0.00 (0.00%)
Inactive · Last trade price on Aug 8, 2025

Turnstone Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--19.3173.3101.29
Revenue Growth
---73.66%-27.64%-
Gross Profit
-55.63-56.93-41.08-6.3848.21
Operating Income
-45.29-73.32-58.92-24.6134.66
Net Income
-47.2-70.84-55.24-31.023.48
Earnings Per Share
-2.05-3.07-4.78-12.491.28
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16.6928.9394.7882.06161.02
Total Debt
0.411.193.215.172.68
Net Cash (Debt)
16.2827.7491.5676.9158.34
Net Cash Growth
-72.96%-69.71%19.07%-51.44%-
Net Cash Per Share
0.701.207.9230.9558.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-45.45-67.44-66.15-71.06-45.63
Capital Expenditures
0.02-0.23-1.25-5.17-3.41
Free Cash Flow
-45.43-67.67-67.4-76.23-49.04
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---212.76%-8.71%47.59%
Operating Margin
---305.21%-33.57%34.22%
Pretax Margin
---287.40%-41.87%33.27%
Profit Margin
---286.12%-42.33%3.44%
FCF Margin
---349.12%-104.00%-48.41%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.04--